Performance analysis of Artiva Biotherapeutics (ARTV)
Annual Return
Since Jul 19, 2024, ARTV has had an average annual return of -12.66%, underperforming the benchmark SPY, which returned +17.60% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +113.29% | -57.44% | -16.00% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.31% | +49.60% | +10.66% | +58.99% | -22.56% | +22.32% | -5.67% | +113.29% | |||||
| 2025 | -49.61% | -18.31% | -27.70% | -20.32% | -19.28% | -21.77% | +98.73% | +5% | -8.88% | +45.28% | -9.84% | +14.11% | -57.44% |
| 2024 | -1.67% | -2.20% | +33.88% | -34.37% | +26.04% | -21.13% | -16.00% |
Drawdown analysis of Artiva Biotherapeutics (ARTV)
The maximum drawdown for the ARTV was -90.71%, occurring on Jun 27, 2025. This drawdown has not yet recovered.
The current ARTV drawdown is -42.20%.
Since Jul 19, 2024 ARTV has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -90.71% | Oct 4, 2024 | 181 | Jun 27, 2025 | Ongoing | Ongoing | Ongoing |
| -18.47% | Sep 6, 2024 | 6 | Sep 16, 2024 | 4 | Sep 20, 2024 | 10 |
| -16.99% | Jul 23, 2024 | 22 | Aug 22, 2024 | 10 | Sep 6, 2024 | 32 |
| -11.85% | Sep 25, 2024 | 1 | Sep 26, 2024 | 2 | Sep 30, 2024 | 3 |
| -2.04% | Oct 2, 2024 | 1 | Oct 3, 2024 | 1 | Oct 4, 2024 | 2 |
| -1.92% | Jul 19, 2024 | 1 | Jul 22, 2024 | 1 | Jul 23, 2024 | 2 |
| -0.19% | Sep 30, 2024 | 1 | Oct 1, 2024 | 1 | Oct 2, 2024 | 2 |